ADMA BIOLOGICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ADMA BIOLOGICS, INC. (ADMA) reported Cash and Cash Equivalents, Period Increase (Decrease) of $6.04 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-05-12
- ADMA BIOLOGICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was $6.04M, a 91.88% decline year-over-year.
- ADMA BIOLOGICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-12-31 was -$3.75M.
- ADMA BIOLOGICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-09-30 was -$16.11M.
- ADMA BIOLOGICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-06-30 was -$25.45M, a 144.59% decline year-over-year.
- ADMA BIOLOGICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2020 was $29.17M.
- ADMA BIOLOGICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$2.72K.
- ADMA BIOLOGICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$21.85M, a 156.48% decline from fiscal 2017.
- ADMA BIOLOGICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $38.69M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 64 month | Cash and Cash Equivalents, Period Increase (Decrease) 67 month |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | $6.04M 10-Q · filed 2021-05-12 | $2.29M derived: sum of 2 quarters · filed 2021-05-12 | -$13.82M derived: sum of 3 quarters · filed 2021-05-12 | -$39.27M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2020-12-31 | -$3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$19.86M derived: sum of 2 quarters · filed 2021-03-25 | -$45.31M derived: sum of 3 quarters · filed 2021-03-25 | $29.17M 10-K · filed 2021-03-25 | |||
| 2020-09-30 | -$16.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$41.56M derived: sum of 2 quarters · filed 2020-11-05 | $32.92M 10-Q · filed 2020-11-05 | $11.67M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2020-06-30 | -$25.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $49.03M 10-Q · filed 2020-08-05 | $27.77M derived: sum of 3 quarters · filed 2021-05-12 | $2.17M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2020-03-31 | $74.48M 10-Q · filed 2021-05-12 | $53.23M derived: sum of 2 quarters · filed 2021-05-12 | $27.62M derived: sum of 3 quarters · filed 2021-05-12 | $84.70M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | -$21.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$46.86M derived: sum of 2 quarters · filed 2021-03-25 | $10.22M derived: sum of 3 quarters · filed 2021-03-25 | -$2.72K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$25.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $31.47M derived: sum of 2 quarters · filed 2020-11-05 | $21.25M 10-Q · filed 2020-11-05 | $1.64M derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-30 | $57.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $46.86M 10-Q · filed 2020-08-05 | $27.25M derived: sum of 3 quarters · filed 2020-08-05 | $14.46M derived: sum of 4 quarters · filed 2020-08-05 | |||
| 2019-03-31 | -$10.22M 10-Q · filed 2020-05-06 | -$29.83M derived: sum of 2 quarters · filed 2020-05-06 | -$42.62M derived: sum of 3 quarters · filed 2020-05-06 | -$15.09M derived: sum of 4 quarters · filed 2020-05-06 | |||
| 2018-12-31 | -$19.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$32.40M derived: sum of 2 quarters · filed 2020-03-13 | -$4.86M derived: sum of 3 quarters · filed 2020-03-13 | -$21.85M 10-K · filed 2020-03-13 | |||
| 2018-09-30 | -$12.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $14.75M derived: sum of 2 quarters · filed 2019-11-06 | -$2.24M 10-Q · filed 2019-11-06 | $32.77M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2018-06-30 | $27.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $10.55M 10-Q · filed 2019-08-08 | $45.55M derived: sum of 3 quarters · filed 2019-08-08 | $33.58M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | -$16.99M 10-Q · filed 2019-05-08 | $18.02M derived: sum of 2 quarters · filed 2019-05-08 | $6.05M derived: sum of 3 quarters · filed 2019-05-08 | $23.08M derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $35.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $23.03M derived: sum of 2 quarters · filed 2019-03-13 | $40.06M derived: sum of 3 quarters · filed 2019-03-13 | $38.69M 10-K · filed 2019-03-13 | |||
| 2017-09-30 | -$11.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $5.06M derived: sum of 2 quarters · filed 2018-11-09 | $3.69M 10-Q · filed 2018-11-09 | $5.70M derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | $17.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $15.66M 10-Q · filed 2018-08-10 | $17.67M derived: sum of 3 quarters · filed 2018-08-10 | $13.02M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2017-03-31 | -$1.37M 10-Q · filed 2018-05-14 | $636.95K derived: sum of 2 quarters · filed 2018-05-14 | -$4.01M derived: sum of 3 quarters · filed 2018-05-14 | -$382.20K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$2.63M derived: sum of 2 quarters · filed 2018-03-29 | $989.74K derived: sum of 3 quarters · filed 2018-03-29 | -$526.09K 10-K · filed 2018-03-29 | |||
| 2016-09-30 | -$4.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$1.02M derived: sum of 2 quarters · filed 2017-11-03 | -$2.53M 10-Q · filed 2017-11-03 | -$1.27M derived: sum of 4 quarters · filed 2017-11-03 | |||
| 2016-06-30 | $3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $2.11M 10-Q · filed 2017-08-11 | $3.37M derived: sum of 3 quarters · filed 2017-08-11 | $4.73M derived: sum of 4 quarters · filed 2017-08-11 | |||
| 2016-03-31 | -$1.52M 10-Q · filed 2017-05-12 | -$252.63K derived: sum of 2 quarters · filed 2017-05-12 | $1.10M derived: sum of 3 quarters · filed 2017-05-12 | -$7.64M derived: sum of 4 quarters · filed 2017-05-12 | |||
| 2015-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $2.62M derived: sum of 2 quarters · filed 2017-02-24 | -$6.12M derived: sum of 3 quarters · filed 2017-02-24 | -$6.76M 10-K · filed 2017-02-24 | |||
| 2015-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$7.39M derived: sum of 2 quarters · filed 2016-11-10 | -$8.02M 10-Q · filed 2016-11-10 | -$4.77M derived: sum of 4 quarters · filed 2016-11-10 | |||
| 2015-06-30 | -$8.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$9.38M 10-Q · filed 2016-08-12 | -$6.13M derived: sum of 3 quarters · filed 2016-08-12 | -$10.05M derived: sum of 4 quarters · filed 2016-08-12 | |||
| 2015-03-31 | -$634.84K 10-Q · filed 2016-05-13 | $2.61M derived: sum of 2 quarters · filed 2016-05-13 | -$1.30M derived: sum of 3 quarters · filed 2016-05-13 | -$9.95M derived: sum of 4 quarters · filed 2016-05-13 | |||
| 2014-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | -$670.00K derived: sum of 2 quarters · filed 2016-03-23 | -$9.32M derived: sum of 3 quarters · filed 2016-03-23 | -$8.95M 10-K · filed 2016-03-23 | |||
| 2014-09-30 | -$3.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$12.57M derived: sum of 2 quarters · filed 2015-11-10 | -$12.20M 10-Q · filed 2015-11-10 | $8.57M derived: sum of 4 quarters · filed 2015-11-10 | |||
| 2014-06-30 | -$8.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$8.28M 10-Q · filed 2015-08-11 | $12.49M derived: sum of 3 quarters · filed 2015-08-11 | $10.22M derived: sum of 4 quarters · filed 2015-08-11 | |||
| 2014-03-31 | $368.48K 10-Q · filed 2015-05-12 | $21.14M derived: sum of 2 quarters · filed 2015-05-12 | $18.86M derived: sum of 3 quarters · filed 2015-05-12 | $16.20M derived: sum of 4 quarters · filed 2015-05-12 | |||
| 2013-12-31 | $20.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $18.50M derived: sum of 2 quarters · filed 2015-03-09 | $15.83M derived: sum of 3 quarters · filed 2015-03-09 | $13.61M 10-K · filed 2015-03-09 | |||
| 2013-09-30 | -$2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$4.94M derived: sum of 2 quarters · filed 2014-11-10 | -$7.16M 10-Q · filed 2014-11-10 | -$5.34M derived: sum of 4 quarters · filed 2014-11-10 | |||
| 2013-06-30 | -$2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$4.88M 10-Q · filed 2014-08-11 | -$3.07M derived: sum of 3 quarters · filed 2014-08-11 | -$5.19M derived: sum of 4 quarters · filed 2014-08-11 | |||
| 2013-03-31 | -$2.22M 10-Q · filed 2014-05-12 | -$399.88K derived: sum of 2 quarters · filed 2014-05-12 | -$2.52M derived: sum of 3 quarters · filed 2014-05-12 | -$3.92M derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$305.86K derived: sum of 2 quarters · filed 2014-03-28 | -$1.70M derived: sum of 3 quarters · filed 2014-03-28 | $12.45M 10-K · filed 2014-03-28 | |||
| 2012-09-30 | -$2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$3.52M derived: sum of 2 quarters · filed 2013-11-12 | $10.63M 10-Q · filed 2013-11-12 | $10.63M derived: sum of 4 quarters · filed 2013-11-12 | |||
| 2012-06-30 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $12.75M 10-Q · filed 2013-08-12 | $12.80M 10-Q · filed 2012-08-14 | $12.76M derived: sum of 3 quarters · filed 2013-08-12 | $12.75M derived: sum of 4 quarters · filed 2013-08-12 | ||
| 2012-03-31 | $14.15M 10-Q · filed 2013-05-14 | $14.15M derived: sum of 2 quarters · filed 2013-05-14 | $14.15M derived: sum of 3 quarters · filed 2013-05-14 | $14.16M derived: sum of 4 quarters · filed 2013-05-14 | |||
| 2011-12-31 | $2.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | -$433.00 10-Q · filed 2012-02-01 | $6.32K derived: sum of 3 quarters · filed 2012-08-14 | -$141.20K 10-K · filed 2013-03-06 | $8.08K 10-Q · filed 2012-02-01 | ||
| 2011-09-30 | -$2.60K 10-Q · filed 2011-10-28 | $4.15K derived: sum of 2 quarters · filed 2012-08-14 | -$224.77K 10-Q · filed 2012-11-13 | -$143.84K derived: sum of 4 quarters · filed 2012-08-14 | $5.91K 10-Q · filed 2011-10-28 | ||
| 2011-06-30 | $6.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$140.72K 10-Q · filed 2012-08-14 | -$141.24K derived: sum of 3 quarters · filed 2012-08-14 | -$149.63K derived: sum of 4 quarters · filed 2012-08-14 | |||
| 2011-03-31 | -$147.47K 10-Q · filed 2012-05-15 | -$147.99K derived: sum of 2 quarters · filed 2012-05-15 | -$156.38K derived: sum of 3 quarters · filed 2012-05-15 | ||||
| 2010-12-31 | -$519.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | -$8.91K 10-Q · filed 2012-02-01 | |||||
| 2010-09-30 | -$8.39K 10-Q · filed 2011-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |